https://univdatos.com/reports/molecular-diagnostics-market

Impact of COVID-19 on the Point of Care Molecular Diagnostics Industry: Assessment https://www.marketsandmarkets.com/Market-Reports/point-of-care-molecular-diagnostic-market-143524127.html The global point-of-care molecular diagnostics market size is projected to reach USD 3.4 billion by 2028 from USD 2.0 billion in 2023, at a CAGR of 10.6% during the forecast period. Growth in the point-of-care molecular diagnostics industry is mainly driven by factors such as the increasing incidence of infectious diseases and cancer, increasing R&D funding to reduce time required for testing, growing awareness about early diagnosis of testing and technological advancements. The major players in this market are Abbott Laboratories (US), F. Hoffmann-La Roche Ltd. (Switzerland), bioMérieux SA (France), Danaher Corporation (US), QIAGEN N.V. (Netherlands), QuidelOrtho Corporation (US), Co-Diagnostics, Inc. (US), Biocartis NV (Belgium), Meridian Bioscience, Inc. (US), Thermo Fisher Scientific, Inc. (US), Lucira Health, Inc. (US), Cue Health (US), OpGen, Inc. (US), Binx Health, Inc. (US), Molbio Diagnostics Pct. Ltd. (India), Genomadix (Canada), Visby Medical, Inc. (US), QuikPath PTE Ltd. (Singapore), MD-Bio (US), QuantuMDx Group Ltd. (UK), Aidian Oy (Finland), GeneSTAT Molecular Diagnostics, LLC. (US), Labsystems Diagnostics Oy (Finland), Akonni Biosystems (US) and Curetis N.V. (Germany).

Veterinary Molecular Diagnostics Market Growth | Top Company Shares, Regional Forecasts to 2030 The New Veterinary Molecular Diagnostics Market Report, offering growth, trends, and forecast for each segment along with regional and country analysis. The study has done with respect to market share, size, trends, growth, outlook, estimation and forecast period 2023-2030. Browse Global Veterinary Molecular Diagnostics Market Research Report with detailed TOC athttps://www.valuemarketresearch.com/report/veterinary-molecular-diagnostics-market

Covid-19 Impact on Molecular Diagnostics Market to Witness a Handsome Growth During 2022-2027 The molecular diagnostics market was estimated at USD 23.6 billion in 2021 and is likely to grow at a CAGR of 4.6% during 2022-2027 to reach USD 30.9 billion by 2027. Read More: https://www.stratviewresearch.com/417/molecular-diagnostics-market.html